904
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluation

Intramuscular Midazolam for treatment of Status Epilepticus

, , , , ORCID Icon &
Pages 37-44 | Received 29 Apr 2020, Accepted 11 Aug 2020, Published online: 25 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Simona Lattanzi, Antonella Riva & Pasquale Striano. (2021) Ganaxolone treatment for epilepsy patients: from pharmacology to place in therapy. Expert Review of Neurotherapeutics 21:11, pages 1317-1332.
Read now

Articles from other publishers (3)

Marzieh Rostaminejad & Akbar Rostaminejad. (2022) Treatment of refractory status epilepticus with intravenous anesthetic agents: A systematic review. Trends in Anaesthesia and Critical Care 44, pages 8-19.
Crossref
Sulaiman Almohaish, Melissa Sandler & Gretchen M. Brophy. (2021) Time Is Brain: Acute Control of Repetitive Seizures and Status Epilepticus Using Alternative Routes of Administration of Benzodiazepines. Journal of Clinical Medicine 10:8, pages 1754.
Crossref
Marios Charalambous, Holger A. Volk, Luc Van Ham & Sofie F. M. Bhatti. (2021) First-line management of canine status epilepticus at home and in hospital-opportunities and limitations of the various administration routes of benzodiazepines. BMC Veterinary Research 17:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.